Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/01/2012EP1971604B1 Pyrrolo-pyridine derivatives for the treatment of cancer diseases
08/01/2012EP1954288B1 Amidine derivatives and their uses as medicine
08/01/2012EP1948174B1 Fluridone as an anti-inflammatory agent
08/01/2012EP1940797B1 8-substituted benzoazepines as toll-like receptor modulators
08/01/2012EP1932833B1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
08/01/2012EP1931660B1 Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
08/01/2012EP1915994B1 Cyclic amine derivatives in combination with ppar regulators
08/01/2012EP1896040B1 Phosphoramidate alkylator prodrugs
08/01/2012EP1888543B1 Apoptosis promoters
08/01/2012EP1885328B1 Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
08/01/2012EP1871749B1 Selurampanel
08/01/2012EP1871345B1 Nanoparticulate erlotinib formulations
08/01/2012EP1869011B1 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
08/01/2012EP1859801B1 Therapeutic agent and prophylactic agent for endometriosis and adenomyosis uteri
08/01/2012EP1856098B1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/01/2012EP1848718B1 Inhibitors of e1 activating enzymes
08/01/2012EP1848426B1 Tricyclic cytoprotective compounds
08/01/2012EP1846415B1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
08/01/2012EP1830816B1 Solid dosage form comprising proton pump inhibitor and suspension made thereof
08/01/2012EP1819697B1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
08/01/2012EP1806152B1 Drug for external use and adhesive patch
08/01/2012EP1799663B1 Modulators of HCV replication
08/01/2012EP1797183B1 Regulation of oncogenes by micrornas
08/01/2012EP1794159B1 7-azaindoles and their use as ppar agonists
08/01/2012EP1753421B1 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
08/01/2012EP1734918B1 Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
08/01/2012EP1713467B1 Compositions and methods of use of a-type procyanidins
08/01/2012EP1708701B1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/01/2012EP1703913B1 Use of ribose in recovery from anaesthesia
08/01/2012EP1669080B1 Method of inhibiting alveolar resorption and peridental membrane loss and composition for internal use to be used therein
08/01/2012EP1666472B1 Phenylacetic acid derivative, process for producing the same, and use
08/01/2012EP1585757B1 Peptide deformylase inhibitors
08/01/2012EP1560585B1 Dosage form that is safeguarded from abuse
08/01/2012EP1545634B1 Method of preparing dry powder inhalation compositions
08/01/2012EP1536810B1 Extraction of pharmaceutically active cannabinoids from plant materials
08/01/2012EP1465615B1 Tricyclic-bis-enone derivatives and methods of use thereof
08/01/2012EP1425000B1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012EP1389120B1 Use of nystatin for the treatment of atherosclerosis linked to the presence of parasitic fungi
08/01/2012EP1369133B1 Gene carriers comprising a beta-1,3-glucan and process for producing the same
08/01/2012EP1303192B1 Dietary lipids for improving skin and coat of pets
08/01/2012EP0961612B2 Protein stabilized pharmacologically active agents and their use
08/01/2012CN1993333B Triazole derivative
08/01/2012CN1918137B Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/01/2012CN1534010B Water soluble extract of red sage root and its preparation method and use
08/01/2012CN1224610B Ibuprofen compositions
08/01/2012CN102625842A Compositions and methods for the delivery of biologically active RNAs
08/01/2012CN102625841A Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)
08/01/2012CN102625840A Tricyclo-DNA antisense oligonucleotides, compositions, and methods for the treatment of disease
08/01/2012CN102625836A Nucleic acid molecule capable of binding to HMGB1, and use thereof
08/01/2012CN102625808A Spirocyclic amide derivatives
08/01/2012CN102625807A 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
08/01/2012CN102625805A Compounds and compositions for treating cancer
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102625800A Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
08/01/2012CN102625799A Heterocyclic compounds and their uses
08/01/2012CN102625798A Substituted quinolines for use as VEGF inhibitors
08/01/2012CN102625797A Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
08/01/2012CN102625791A Method for isolating cimiracemate A
08/01/2012CN102625711A Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
08/01/2012CN102625705A A plant extract comprising statins and preparation techniques and uses thereof
08/01/2012CN102625704A FGF receptor-activating N-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/01/2012CN102625703A Pregnenolone sulfate for the treatment of neurologic disorders
08/01/2012CN102625702A Imatinib immunoassay
08/01/2012CN102625701A Modulation of systemic exposure to rifaximin
08/01/2012CN102625700A Galantamine amino acid and peptide prodrugs and uses thereof
08/01/2012CN102625699A Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
08/01/2012CN102625696A Improved lipid formulation
08/01/2012CN102625661A Methods for preventing and/or treating lysosomal storage disorders
08/01/2012CN102625660A Iminosugars and methods of treating arenaviral infections
08/01/2012CN102625659A An automated method and system for the analysis of Total Dietary Fiber
08/01/2012CN102625657A Low frequency glatiramer acetate therapy
08/01/2012CN102625656A Treating critically ill patients with intravenous ibuprofen
08/01/2012CN102618547A Nucleic acid aptamer rich in guanine
08/01/2012CN102618545A Gene involved in immortalization of human cancer cell and use thereof
08/01/2012CN102618448A Drimane-type sesquialter terpene cyclohexenone derivative, preparation method thereof and application
08/01/2012CN102617893A Preparation and application of composition of panaxoside Rg3, ginseng polysaccharide and ganoderan
08/01/2012CN102617745A Preparation method and blood sugar lowering function of Ganoderma lucidum karst polysaccharide F31
08/01/2012CN102617698A Method for preparing fine dioscin and application of fine dioscin
08/01/2012CN102617690A Vitamin d derivatives
08/01/2012CN102617680A Bi-functional antiplatelet aggregation medicine and application thereof
08/01/2012CN102617679A Preparation method and application of connected conjugated linoleic acid and gemcitabine prodrug
08/01/2012CN102617676A Zidovudine quinoline conjugated compound, preparation method thereof and application for liver cancer resistance
08/01/2012CN102617672A Camellia nitidissima flavonoid glycoside, and preparation method and application thereof
08/01/2012CN102617664A Plumbagin-5-O-glucose and synthetic method and application thereof
08/01/2012CN102617641A Fosinopril sodium compound and preparation method thereof
08/01/2012CN102617632A Organic germanium complex, and preparation method and application thereof
08/01/2012CN102617613A High-efficiency antibacterial copper ternary complex containing heterocyclic ligand, and preparation method and application thereof
08/01/2012CN102617612A Biapenem B-type crystallinity
08/01/2012CN102617610A Preparation method of porphyrin photosensitizer and anticarcinogen diad
08/01/2012CN102617609A Indole alkaloid compound, its analog, its medicinal composition, and its use
08/01/2012CN102617605A Ceftriaxone sodium compound and preparation method thereof
08/01/2012CN102617599A Macrocyclic compound and application thereof
08/01/2012CN102617596A Dimeric sesquiterpene compound Hippolide I, its preparation method and its purpose
08/01/2012CN102617594A Prasugrel eutectic and preparation method, medicinal composition and application thereof
08/01/2012CN102617588A Anti-tumor compound, and preparation method and application thereof
08/01/2012CN102617585A Furocoumarin derivative, preparation method thereof and use thereof
08/01/2012CN102617584A Irinotecan hydrochloride compound and medicinal composition thereof
08/01/2012CN102617582A Triazole epothilone analogue, drug composition thereof, preparation method of triazole epothilone and application
08/01/2012CN102617580A Vasopressin V1a Antagonists
1 ... 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 ... 7860